Merck properly denied extra period of exclusivity for cladribine, UK panel says
MLex Summary: The UK Court of Appeal turned down calls by Merck Serono to undo their endorsement last year in Newron Pharmaceuticals v. Comptroller of the European Court of Justice 2020...To view the full article, register now.
Already a subscriber? Click here to view full article